Stefano; James
Patent Applications and Registrations
Patent applications and USPTO patent grants for Stefano; James.The latest application filed is for "site-specific antibody-drug conjugation through glycoengineering".
- Stefano; James - Hopkinton MA
- Stefano; James - Bridgewater NJ
- Stefano; James - Cambridge MA
| Patent | Date |
|---|---|
| Site-specific Antibody-drug Conjugation Through Glycoengineering App 20220089763 - Pan; Clark ; et al. | 2022-03-24 |
| Site-specific antibody-drug conjugation through glycoengineering Grant 11,130,816 - Pan , et al. September 28, 2 | 2021-09-28 |
| Bone-Targeting Antibodies App 20210163584 - Qiu; Huawei ; et al. | 2021-06-03 |
| Bone-targeting antibodies Grant 10,844,115 - Qiu , et al. November 24, 2 | 2020-11-24 |
| Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate Grant 10,806,797 - Kadereit , et al. October 20, 2 | 2020-10-20 |
| Targeting of glycoprotein therapeutics Grant 10,792,342 - Stefano October 6, 2 | 2020-10-06 |
| Site-specific Antibody-drug Conjugation Through Glycoengineering App 20190233531 - Pan; Clark ; et al. | 2019-08-01 |
| Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof Grant 10,308,917 - Stefano , et al. | 2019-06-04 |
| Site-specific antibody-drug conjugation through glycoengineering Grant 10,214,589 - Pan , et al. Feb | 2019-02-26 |
| Targeting Of Glycoprotein Therapeutics App 20190054154 - STEFANO; James | 2019-02-21 |
| Prodrugs Comprising An Glp-1/glucagon Dual Agonist Linker Hyaluronic Acid Conjugate App 20180289822 - KADEREIT; Dieter ; et al. | 2018-10-11 |
| Bone-targeting Antibodies App 20180208650 - Qiu; Huawei ; et al. | 2018-07-26 |
| Site-specific Antibody-drug Conjugation Through Glycoengineering App 20170267774 - Pan; Clark ; et al. | 2017-09-21 |
| Site-specific antibody-drug conjugation through glycoengineering Grant 9,580,511 - Pan , et al. February 28, 2 | 2017-02-28 |
| Targeting Of Glycoprotein Therapeutics App 20170042979 - STEFANO; James | 2017-02-16 |
| Targeting of glycoprotein therapeutics Grant 9,498,518 - Stefano November 22, 2 | 2016-11-22 |
| Vegf Antagonist Compositions And Uses Thereof App 20160326501 - Stefano; James ; et al. | 2016-11-10 |
| VEGF antagonist compositions and uses thereof Grant 9,441,029 - Stefano , et al. September 13, 2 | 2016-09-13 |
| Targeting Of Glycoprotein Therapeutics App 20150320844 - Stefano; James | 2015-11-12 |
| Targeting of glycoprotein therapeutics Grant 8,906,379 - Stefano December 9, 2 | 2014-12-09 |
| Site-specific Antibody-drug Conjugation Through Glycoengineering App 20140294867 - PAN; Clark ; et al. | 2014-10-02 |
| Vegf Antagonist Compositions And Uses Thereof App 20130324465 - Stefano; James ; et al. | 2013-12-05 |
| Targeting Of Glycoprotein Therapeutics App 20120141507 - Stefano; James | 2012-06-07 |
| Targeting of glycoprotein therapeutics Grant 8,124,073 - Stefano February 28, 2 | 2012-02-28 |
| Targeting Of Glycoprotein Therapeutics App 20080226658 - Stefano; James | 2008-09-18 |
| Targeting of glycoprotein therapeutics Grant 7,341,720 - Stefano March 11, 2 | 2008-03-11 |
| Targeting of glycoprotein therapeutics App 20060228348 - Stefano; James | 2006-10-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 